HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS

被引：0
|
作者：
Koka, N. S. [1 ]
Syed, A. A. [1 ]
Ahmad, M. [1 ]
Patel, K. [1 ]
Nair, S. [1 ]
Shah, S. [1 ]
机构：
[1] Market Access Solut LLC LTD MKTXS, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA169
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF BIOSIMILAR REIMBURSEMENT POLICIES IN THE US AND SELECT EUROPEAN MARKETS
    Stylianou, M.
    Hinds, C.
    VALUE IN HEALTH, 2024, 27 (06) : S199 - S199
  • [2] HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL & GENE THERAPIES: THE ROAD TO REIMBURSEMENT
    Vu, B. K.
    Forsythe, A.
    Nguyen, K.
    Tomaras, D.
    VALUE IN HEALTH, 2020, 23 : S20 - S20
  • [3] INTERNATIONAL COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS IN PERSONALIZED ONCOLOGY THERAPIES
    Ho, C. Y.
    Gless, P.
    Lawless, G.
    VALUE IN HEALTH, 2017, 20 (05) : A135 - A135
  • [4] HOW ARE PATIENTS INVOLVED IN HEALTH TECHNOLOGY ASSESSMENT? A COMPARATIVE ANALYSIS OF EUROPEAN MARKETS FOR ADVANCED THERAPIES AND IMPLICATIONS FOR JOINT CLINICAL ASSESSMENT
    Swider, A.
    Gonzalez, San Segundo A.
    Lucion, D.
    Hall, S.
    Creasey, A.
    Wright, J.
    Steeds, C.
    Torelli, F.
    VALUE IN HEALTH, 2023, 26 (12) : S376 - S376
  • [5] Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
    Krzysztof Piotr Malinowski
    Paweł Kawalec
    Wojciech Trąbka
    Christoph Sowada
    Guenka Petrova
    Manoela Manova
    Alexandra Savova
    Pero Draganić
    Juraj Slabý
    Agnes Männik
    Kristóf Márky
    Zinta Rugaja
    Jolanta Gulbinovic
    Tomas Tesar
    Marian Sorin Paveliu
    Orphanet Journal of Rare Diseases, 15
  • [6] Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Trabka, Wojciech
    Sowada, Christoph
    Petrova, Guenka
    Manova, Manoela
    Savova, Alexandra
    Draganic, Pero
    Slaby, Juraj
    Mannik, Agnes
    Marky, Kristof
    Rugaja, Zinta
    Gulbinovic, Jolanta
    Tesar, Tomas
    Paveliu, Marian Sorin
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [7] UNDERSTANDING HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES IN MAJOR EUROPEAN MARKETS: SYSTEMATIC EVALUATION IN 10 EU COUNTRIES
    Nanavaty, M.
    Gala, S.
    Nyandege, A.
    Ramesh, V
    Mwamburi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A488 - A488
  • [8] HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES IN SPAIN AND ITALY: KEY METRICS AND CONSIDERATIONS
    Privolnev, Y.
    Moore, R.
    Sharma, K.
    VALUE IN HEALTH, 2018, 21 : S180 - S180
  • [9] Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology
    van Harten, W. H.
    Retel, V. P.
    ECANCERMEDICALSCIENCE, 2016, 10
  • [10] SYSTEMATIC LITERATURE REVIEW REQUIREMENTS FOR HEALTH TECHNOLOGY ASSESSMENT IN EUROPEAN MARKETS
    Wright, C.
    Swanston, A.
    Nicholson, L.
    Marjenberg, Z.
    Pooley, N.
    VALUE IN HEALTH, 2024, 27 (06) : S253 - S253
12345